The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost-effectiveness analysis.
Carlos E Rodriguez-MartinezMonica P Sossa-BriceñoJefferson Antonio BuendiaPublished in: Pediatric pulmonology (2021)
In Colombia, when compared to therapy with SABAs alone, therapy with a combination of SABAs and IB for treating pediatric patients with moderate to severe asthma exacerbations involves a lower probability of hospital admission at lower treatment costs.